These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9466172)

  • 61. Moclobemide and fluoxetine in treatment of seasonal affective disorder.
    Partonen T; Lönnqvist J
    J Affect Disord; 1996 Nov; 41(2):93-9. PubMed ID: 8961036
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Psychometric alterations in treatment with the MAO-A-inhibitor moclobemide.
    Classen W; Laux G
    J Neural Transm Suppl; 1990; 32():185-8. PubMed ID: 2089088
    [TBL] [Abstract][Full Text] [Related]  

  • 63. An open study of the efficacy and adverse effects of moclobemide in patients with the chronic fatigue syndrome.
    White PD; Cleary KJ
    Int Clin Psychopharmacol; 1997 Jan; 12(1):47-52. PubMed ID: 9179634
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Moclobemide in social phobia: a pilot open study. GRP Group. Groupe de Recherche en Psychopharmacologie.
    Bisserbe JC; Lépine JP
    Clin Neuropharmacol; 1994; 17 Suppl 1():S88-94. PubMed ID: 7954487
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy of a reversible monoamine oxidase-A inhibitor versus imipramine in subgroups of depressed patients.
    Bizière K; Berger M
    Acta Psychiatr Scand Suppl; 1990; 360():59-60. PubMed ID: 2248074
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Fluoxetine: therapeutic and undesirable effects.
    Cookson J; Duffett R
    Hosp Med; 1998 Aug; 59(8):622-6. PubMed ID: 9829055
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interaction between moclobemide and oral tyramine in depressed patients.
    Burgess CD; Mellsop GW
    Fundam Clin Pharmacol; 1989; 3(1):47-52. PubMed ID: 2714732
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Placebo-controlled trial of moclobemide in social phobia.
    Schneier FR; Goetz D; Campeas R; Fallon B; Marshall R; Liebowitz MR
    Br J Psychiatry; 1998 Jan; 172():70-7. PubMed ID: 9534836
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment of winter depression in Norway. II. A comparison of the selective monoamine oxidase A inhibitor moclobemide and placebo.
    Lingjaerde O; Reichborn-Kjennerud T; Haggag A; Gärtner I; Narud K; Berg EM
    Acta Psychiatr Scand; 1993 Nov; 88(5):372-80. PubMed ID: 8296582
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Controlled comparison of RO 11-1163 (moclobemide) and placebo in the treatment of depression.
    Botte L; Evrard JL; Gilles C; Stenier P; Wolfrum C
    Acta Psychiatr Belg; 1992; 92(6):355-69. PubMed ID: 1345409
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Moclobemide--placebo-controlled trials.
    Silverstone T
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):133-6. PubMed ID: 8468433
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Therapeutic efficacy of antidepressants in agitated anxious depression--a meta-analysis of moclobemide studies.
    Delini-Stula A; Mikkelsen H; Angst J
    J Affect Disord; 1995 Oct; 35(1-2):21-30. PubMed ID: 8557884
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Moclobemide versus amitriptyline in the treatment of depression: two small double-blind multicentre studies in Belgium.
    Beckers G; Vereecken A; de Bleeker E; Jaunes C; Sieben G; Faidherbe J; Wolfrum C; Berger M; Hellstern K; Ward J
    Acta Psychiatr Scand Suppl; 1990; 360():52-3. PubMed ID: 2248072
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states.
    Stabl M; Biziére K; Schmid-Burgk W; Amrein R
    J Neural Transm Suppl; 1989; 28():77-89. PubMed ID: 2677244
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Double-blind randomized controlled study of the efficacy and tolerability of two reversible monoamine oxidase A inhibitors, pirlindole and moclobemide, in the treatment of depression.
    Tanghe A; Geerts S; Van Dorpe J; Brichard B; Bruhwyler J; Géczy J
    Acta Psychiatr Scand; 1997 Aug; 96(2):134-41. PubMed ID: 9272198
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults. The Australian and German Study Groups.
    Philipp M; Tiller JW; Baier D; Kohnen R
    Eur Neuropsychopharmacol; 2000 Sep; 10(5):305-14. PubMed ID: 10974600
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Switch in treatment from tricyclic antidepressants to moclobemide: a new generation monoamine oxidase inhibitor.
    Dingemanse J; Kneer J; Fotteler B; Groen H; Peeters PA; Jonkman JH
    J Clin Psychopharmacol; 1995 Feb; 15(1):41-8. PubMed ID: 7714227
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Acute therapy of depression.
    Bech P
    J Clin Psychiatry; 1993 Aug; 54 Suppl():18-27; discussion 28. PubMed ID: 8253702
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical efficacy of reversible and selective inhibitors of monoamine oxidase A in major depression.
    Paykel ES
    Acta Psychiatr Scand Suppl; 1995; 386():22-7. PubMed ID: 7717091
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy and adverse effects of moclobemide.
    Brodribb TR; Downey M; Gilbar PJ
    Lancet; 1994 Feb; 343(8895):475. PubMed ID: 7905962
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.